Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary AngioplastyJuan Antonio Suárez-Cuenca 1, Rogelio Robledo-Nolasco 2, Marco Antonio Alcántara-Meléndez 2, Luis Javier Díaz-Hernandez 1, Eduardo Vera-Gómez 1, Alejandro Hernández-Patricio 1, Karla Susana Sánchez-Díaz 1, Juan Ariel Gutiérrez-Buendía 1, Alejandra Contreras-Ramos 3, Atzin Suá Ruíz-Hernández 1, Rebeca Pérez-Cabeza de Vaca 1, Paul Mondragón-Terán 1
1Experimental Metabolism and Clinical Research Laboratory & Regenerative Medicine and Tissue Engineering Laboratory, 2Hemodynamics Unit, Cardiology Department, Centro Médico Nacional "20 de Noviembre" ISSSTE, 3Laboratorio de Biología del Desarrollo y Teratogénesis Experimental, Hospital Infantil de México Federico Gómez
Development of major adverse cardiovascular events, which impact cardiovascular prognosis after coronary angioplasty, are influenced by the extent of coronary damage and vascular repair. The use of novel coronary cellular and soluble biomarkers, reactive to vascular damage and repair, are useful to predict the development of MACEs and prognosis.
